GlobeStar Therapeutics Corp Quarterly Accounts Payable, Current in USD from Q3 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
GlobeStar Therapeutics Corp quarterly Accounts Payable, Current history and growth rate from Q3 2012 to Q2 2024.
  • GlobeStar Therapeutics Corp Accounts Payable, Current for the quarter ending June 30, 2024 was $435K, a 117% increase year-over-year.
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $435K +$235K +117% Jun 30, 2024 10-Q 2024-10-11
Q1 2024 $408K +$245K +151% Mar 31, 2024 10-Q 2024-06-28
Q4 2023 $366K +$229K +166% Dec 31, 2023 10-Q 2024-03-12
Q3 2023 $328K -$52.6K -13.8% Sep 30, 2023 10-Q 2024-10-11
Q2 2023 $200K Jun 30, 2023 10-Q 2023-08-17
Q1 2023 $163K Mar 31, 2023 10-Q 2023-05-31
Q4 2022 $138K Dec 31, 2022 10-Q 2023-02-13
Q3 2022 $381K Sep 30, 2022 10-K 2024-01-19
Q2 2015 $252K +$63.1K +33.4% Jun 30, 2015 10-Q/A 2015-09-24
Q1 2015 $355K +$197K +125% Mar 31, 2015 10-Q/A 2015-09-17
Q4 2014 $268K +$115K +74.4% Dec 31, 2014 10-Q 2015-02-17
Q3 2014 $246K +$132K +117% Sep 30, 2014 10-Q/A 2015-09-24
Q2 2014 $189K Jun 30, 2014 10-Q/A 2014-09-04
Q1 2014 $158K Mar 31, 2014 10-Q 2014-05-20
Q4 2013 $154K Dec 31, 2013 10-Q/A 2014-02-21
Q3 2013 $114K +$85K +298% Sep 30, 2013 10-Q/A 2014-09-04
Q3 2012 $28.6K Sep 30, 2012 10-K/A 2014-01-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.